Comparing the current results to its competitors, Strata Skin Sciences Inc reported Revenue decrease in the 4 quarter 2025 year on year by -2.97 %, despite the revenue increase by the most of its competitors of 9.15 %, recorded in the same quarter.
Strata Skin Sciences Inc's Comment on Competition and Industry Peers
The company's XTRAC product line competes with pharmaceutical compounds and treatment methodologies for various skin conditions, including topical products, systemic medications, and phototherapies offered by both large pharmaceutical firms and smaller device companies. Key competitors in dermatological solutions include The Daavlin Company, National Biologic Corporation, and pharmaceutical companies producing topical, systemic, and biologic medications. The XTRAC system is noted for its clinical effectiveness, minimal side effects, cost-efficiency, and reimbursement support. Additionally, the TheraClear device competes with over-the-counter treatments, prescription medications, and in-office treatment methods.
July 22, 2024
STRATA Skin Sciences Announces Regulatory Approval of XTRAC Momentum 1.0 Device in JapanHORSHAM, Penn., July 22, 2024 STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a leader in medical technology focused on the development, commercialization, and marketing of innovative dermatologic treatments, has announced the official approval of its XTRAC Momentum 1.0 device by Japan s Ministry of Health, Labor and Welfare. The regulatory green light will allow STRATA to implement an immediate commercial rollout in partnership with JMEC Co., Ltd., its longstanding strategic partner and distributor in Japan. The XTRAC Momentum 1.0 device initially made its debut in the U.S. market in early 2022. Its introduction to the Jap...
July 17, 2024
Acne is one of the most common skin conditions affecting millions of individuals worldwide. It not only leads to physical symptoms like redness, inflammation, and scarring but also impacts psychological well-being, self-esteem, and quality of life. As a result, finding effective acne treatment options is crucial. This article examines the groundbreaking study published in the Journal of Cosmetic and Laser Therapy that highlights the safety and efficacy of the STRATA Skin Sciences TheraClearX Acne Therapy System as a potential monotherapy or combination therapy for individuals with mild to moderate acne.Background:The TheraClearX Acne Therapy System has been developed as an innovative approach to combat acne....
December 29, 2023
Strata Skin Sciences, a leading medical technology company targeting dermatology and plastic surgery, has recently announced the expansion of its distribution agreement with Kosmo Meditech, an Asian-based medical technology company. This strategic step significantly bolsters the relationship between the two companies, potentially enabling Strata Skin Sciences to penetrate deeper into the burgeoning Asian medical technology market. To outline the facts gathered from the announcement, the existing partnership between Strata Skin Sciences and Kosmo Meditech has been a source of steady growth for both companies. The drive behind the expansion is primarily to consolidate this growth and leverage each other s stre...
Conmed Corporation operates as a global medical technology company that develops, manufactures, and markets surgical devices and equipment for minimally invasive procedures.
Inmode Ltd is a medical technology company that specializes in developing and commercializing minimally invasive aesthetic and medical solutions. They primarily operate on a direct-to-consumer model, selling their devices to physicians, medical spas, and clinics. In addition to device sales, they generate recurring revenue through consumable product sales and service contracts for their devices.
Iridex Corp's business model revolves around providing advanced medical devices and solutions for the treatment of eye conditions, primarily focused on ophthalmology.
Lensar Inc is a medical technology company that operates through a business model focused on the development and commercialization of advanced laser systems for ophthalmic procedures. They aim to provide innovative solutions to healthcare professionals in order to enhance precision, safety, and efficiency in eye surgeries.
Sources:
Strata Skin Sciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Strata Skin Sciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
